Literature DB >> 32513807

What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19?

Seth R Bauer1, Aanchal Kapoor2, Mary Rath3, Suma A Thomas4.   

Abstract

Several agents intended to supplement dietary intake or endogenous molecules may have a theoretical role in preventing or treating COVID-19. Because of their potential to influence immune response, ascorbic acid (vitamin C), zinc, vitamin D, and N-acetylcysteine have been hypothesized to be useful for prevention or treatment of COVID-19. The authors outline the biologic plausibility, applicable clinical data, and potential role of each of these agents.
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Entities:  

Year:  2020        PMID： 32513807     DOI： 10.3949/ccjm.87a.ccc046

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  22 in total

Review 1.  Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19.

Authors:  Kimberly Hall; Fuhbe Mfone; Michael Shallcross; Vikas Pathak
Journal:  Eurasian J Med       Date:  2021-06

2.  Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity.

Authors:  Yasmin Polak; Robert C Speth
Journal:  Peptides       Date:  2021-01-02       Impact factor: 3.750

Review 3.  A Review of the Role of Micronutrients and Bioactive Compounds on Immune System Supporting to Fight against the COVID-19 Disease.

Authors:  Montaña Cámara; María Cortes Sánchez-Mata; Virginia Fernández-Ruiz; Rosa María Cámara; Elena Cebadera; Laura Domínguez
Journal:  Foods       Date:  2021-05-14

Review 4.  The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease.

Authors:  Don A Davies; Aida Adlimoghaddam; Benedict C Albensi
Journal:  Mol Neurobiol       Date:  2021-06-01       Impact factor: 5.590

5.  Practice of adjunctive treatments in critically ill COVID-19 patients-rational for the multicenter observational PRoAcT-COVID study in The Netherlands.

Authors:  Christel M A Valk; Pien Swart; Leonoor S Boers; Michela Botta; Lieuwe D J Bos; Marcelo Gama de Abreu; Liselotte Hol; Markus W Hollmann; Janneke Horn; Ignacio Martin-Loeches; Guido Mazzinari; Sheila N Myatra; Sunny G Nijbroek; Neeltje M Rosenberg; Willemke Stilma; Anissa M Tsonas; Ward H van der Ven; Ary Serpa Neto; Marcus J Schultz; Frederique Paulus
Journal:  Ann Transl Med       Date:  2021-05

Review 6.  The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.

Authors:  Apurva Hariharan; Abdul Rahman Hakeem; Subathra Radhakrishnan; Mettu Srinivas Reddy; Mohamed Rela
Journal:  Inflammopharmacology       Date:  2020-11-07       Impact factor: 4.473

Review 7.  The Long History of Vitamin C: From Prevention of the Common Cold to Potential Aid in the Treatment of COVID-19.

Authors:  Giuseppe Cerullo; Massimo Negro; Mauro Parimbelli; Michela Pecoraro; Simone Perna; Giorgio Liguori; Mariangela Rondanelli; Hellas Cena; Giuseppe D'Antona
Journal:  Front Immunol       Date:  2020-10-28       Impact factor: 7.561

Review 8.  Overview of the possible role of vitamin C in management of COVID-19.

Authors:  Anis Abobaker; Aboubaker Alzwi; Alsalheen Hamed A Alraied
Journal:  Pharmacol Rep       Date:  2020-10-28       Impact factor: 3.024

Review 9.  Gastrointestinal and renal complications in SARS-CoV-2-infected patients: Role of immune system.

Authors:  Fatemeh Maghool; Ali Valiani; Tahereh Safari; Mohammad Hassan Emami; Samane Mohammadzadeh
Journal:  Scand J Immunol       Date:  2020-12-07       Impact factor: 3.889

Review 10.  Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19.

Authors:  Silvio De Flora; Roumen Balansky; Sebastiano La Maestra
Journal:  FASEB J       Date:  2020-08-11       Impact factor: 5.834
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.